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It is well known that β-adrenoceptors (β-ARs) play a critical role in emotional arousal and
stressful events, but the specific contributions of the β2-AR subtype to the psychological
disorders are largely unknown. To investigate whether β2-AR are involved in anxiety-like
behavior and reward to addictive drugs, we conducted a series of behavioral tests
on β2-AR knock-out (KO) mice. β2-AR KO mice exhibited increased preference for
the dark compartment and closed arm in tests of Light/Dark box and elevated plus
maze, indicating that β2-AR deletion elevates level of anxiety or innate fear. β2-AR KO
mice also showed decreased immobility in tail suspension test (TST), suggesting that
β2-AR deletion inhibits depression-like behavior. Interestingly, β2-AR ablation did not
change basal locomotion but significantly increased locomotor activity induced by acute
cocaine administration. β2-AR KO mice showed enhanced place preference for cocaine,
which could be attenuated by β1-selective AR antagonist betaxolol. Consistently,
β2-AR agonist suppressed cocaine-conditioned place preference (CPP). These data
indicate that β2-AR deletion enhances acute response and reward to cocaine. Our
results suggest that β2-AR regulates anxiety level, depression-like behavior and hedonic
properties of cocaine, implicating that β2-AR are the potential targets for the treatment
of emotional disorders and cocaine addiction.
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INTRODUCTION
Anxiety and depression are the common types of psychiatric disorders, with high incidence and
life-long prevalence (Kessler et al., 2005; Mufaddel et al., 2013). Psychological stressors activate
neuroendocrine pathways to release catecholamines, and β-adrenoceptors (β-ARs) play a critical
role in emotional arousal and stressful events (Blanchard et al., 2001). β-ARs, consisting of β1,
β2 and β3 subtypes, are prototypical members of G protein-coupled receptor (GPCR) family. The
β1-AR and β2-AR are abundant in the brain and their functions in the neural system are studied.
Human studies showed that the density of cortical β-ARs were lower among antidepressant-free
depressed suicide victims (De Paermentier et al., 1989). Increased noradrenaline levels in brain lead
to improved emotional memory performance and β-adrenergic antagonists applied in comparable
time-frames lead to reduced memory performance on stress tasks (McGaugh and Introini-Collison,
1987; Cahill et al., 1994; Cahill and Alkire, 2003). Propranolol, a non-selective β-AR antagonist with
equal affinity for both β1- and β2-AR (Rehsia and Dhalla, 2010), was studied as a general anxiolytic
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treatment of anxiety disorders, PTSD and addiction for its
amnesic effect (Famularo et al., 1988; Steenen et al., 2016).
Animal studies showed that stress-induced anxiety-like behavior
and neuronal activation were prevented by propranolol (Wohleb
et al., 2011). Considering many medications non-selectively
modulate the adrenergic system and β1- and β2-AR may be
dissociated functionally, understanding the role of subtypes of
β-ARs in emotional behaviors is important and has significant
clinical implications.
Activation of either subtype of β-ARs results in stimulation
of adenylyl cyclase (Levy et al., 1993), but differences in receptor
distribution and efficacy have been found. β1-AR are in much
higher levels than β2-AR within forebrain structures such as the
cerebral cortex, caudate, hippocampus and amygdala (Ordway
et al., 1988). While isoproterenol, which has equal affinity for
both β1 and β2 subtypes, induces greater adenylyl cyclase activity
upon stimulation of β2-AR than β1-AR (Green et al., 1992). Up
to date, the functions of these subtypes of β-ARs in brain are
not very well distinguished. Especially, the role of β2-AR in the
regulation of emotional behaviors is to be clarified.
Recently, studies focused on the functions of β2-AR in
central nervous system have revealed that prefrontal cortical
β2-AR activate spike-timing-dependent LTP and enhances fear
memory by stimulating postsynaptic cAMP-PKA signaling and
suppressing GABAergic circuit activities (Zhou et al., 2013).
Astrocytic rather than neuronal β2-AR in the hippocampus
plays a key role in the consolidation of contextual fear memory
(Gao et al., 2016). Methyl-CpG-binding protein 2 (MeCP2) gene
is an X-linked gene encoding the MeCP2 protein. Mutation
of this gene may cause neurodevelopmental disorders, such as
Rett syndrome (RTT) and decreased synaptic plasticity (Kishi
and Macklis, 2004; Cronk et al., 2015; Hara et al., 2015;
Lombardi et al., 2015; Tai et al., 2016). β2-AR agonist clenbuterol
rescued deficits in social memory in young male Mecp2-null
and improved memory performance in object recognition
and decreased anxiety in heterozygous (HET) female mice
(Mellios et al., 2014). β2-AR activation stimulates CRF-releasing
neurons in the BNST that interface with motivational neural
circuitry to induce reinstatement of cocaine conditioned reward
(McReynolds et al., 2014). However, the roles of β2-AR in
psychiatric disorders are largely unknown.
In this study, we investigated the potential roles of β2-AR
in regulating emotional behaviors. We showed that β2-AR
knock-out (KO) resulted in increased anxiety in the light-dark
box and elevated plus maze tasks, decreased depression-like
behavior in tail-suspension test (TST), and elevated cocaine-
induced rewarding effects in locomotion and conditioned placed
preference tasks. Our data suggest the necessity of β2-AR in
control of anxiety and response to cocaine.
MATERIALS AND METHODS
Animals
Six-week-old male C57BL/6J mice were purchased form Slaccas
Lab Animal Ltd, Shanghai, China, weighing about 22 g.
β2-AR KO mice were the gift from Prof. Gang Pei (SIBS,
Chinese Academy of Sciences) and backcrossed onto a C57BL/6J
background. Experiments were carried out in wild type (WT),
HET and KO littermates. All animals were housed with a
reversed 12 h light/dark cycle and with access to food and
water available ad libitum. Treatments were strictly in accordance
with the National Institutes of Health Guide for the Care and
Use of Laboratory Animals and were approved by Animal Care
and Use Committee of Shanghai Medical College of Fudan
University. The male mice with 8–10 weeks’ age were used for
all behavioral tests. The behavioral tests were performed in the
following orders: open field (OF), light/dark box and elevated
plus maze tasks were carried out with the first cohort of mice
(WT: n = 26–27, HET: n = 17, KO: n = 27). TST and forced
swimming test (FST) were taken out with the second cohort
(WT: n = 12, HET: n = 18, KO: n = 16). The third cohort
(WT: n = 9, HET: n = 6, KO: n = 9) were submitted to locomotion
tests induced by acute cocaine administration and the forth
cohort (WT: n = 18, HET: n = 8, KO: n = 20) were submitted
to cocaine conditioned place preference (CPP; Figure 1). β2-AR
KO mice and subsequent offspring were genotyped using the
following primer sets: 5′-CAC GAG ACT AGT GAG ACG
TG-3′; 5′-ACC AAG AAT AAGGCC CGAGT-3′; 5′-CCG GGA
ATA GAC AAA GAC CA-3′.
Reagents
Cocaine hydrochloride (Qinghai Pharmaceutical Firm, China)
was dissolved in 0.9% saline at 2 mg/ml for mouse CPP, 4 mg/ml
for locomotor response test. Betaxolol (Tocris Bioscience, UK),
a selective β1-AR antagonist, was dissolved in saline at 2 mg/ml
and administered at a dose of 10 mg/kg (i. p.; Vranjkovic et al.,
FIGURE 1 | Sequence of behavioral tests. The anxiety level and
depression level tests were carried out following the first and second cohorts,
respectively. Acute cocaine response and cocaine conditioned place
preference (CPP) were tested following the third and fourth cohorts,
respectively (the first cohort: wild type (WT) n = 26–27, heterozygous (HET)
n = 17, knock-out (KO) n = 27; the second cohort: WT n = 12, HET n = 18,
KO n = 16; the third cohort: WT n = 9, HET n = 6, KO n = 9; the forth cohort:
WT n = 18, HET n = 8, KO n = 20).
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2012; Al-Hasani et al., 2013). Clenbuterol (Tocris Bioscience,
UK), a selective β2-AR agonist, was dissolved in saline at 1 mg/ml
and administering at a dose of 5 mg/kg (i. p.; Heal et al., 1991;
Mellios et al., 2014). Control animals received an equivalent
volume of saline.
Western Blotting
Mice brains were removed on ice, hippocampus and medial
prefrontal cortex (mPFC) were rapidly dissected and the
tissues were prepared as following. Briefly, brain samples were
homogenized in ice-cold 0.32 M sucrose, 5 mMHEPES (pH 7.4),
0.1 mM EDTA, and protease inhibitors mixture in a glass
homogenizer. Homogenates were centrifuged (1000× g, 10 min,
4◦C), and the supernatants were spun at 14,000× g for 30 min
in a centrifuge at 4◦C. Then the pellets were resuspended
in 200 µL of 1× P buffer (5.4 mM KCl, 0.8 mM MgSO4,
5.5 mM glucose, 50 mM HEPES, 130 mM choline chloride,
1 mM BSA, and 0.01% CHAPS). The protein concentration
was determined by BCA assay (Pierce, 23235). Equal amounts
of total protein (30 µg) isolated from cell membrane of the
hippocampus and mPFC from WT and β2-AR KO mice were
loaded on 10% sodium dodecyl sulfate polyacrylamide gels
and then transferred to polyvinylidene difluoride membranes
(Amersham Pharmacia Biotech, Piscataway, NJ, USA). Then
the membranes were incubated in primary antibody for β1-
AR (1:100, Santa cruz), β2-AR (1:100, Santa cruz) or β-tubulin
(1:2500; Sigma, St Louis, MO, USA) at 4◦C overnight. The
membranes were then incubated with corresponding secondary
antibody (1:50,000, Jackson Immuno Research) for 2 h after
washing in TBST for three times. Protein bands were visualized
using odyssey (LI-COR Biosciences). The immunoblots were
analyzed with Image-Pro Plus to measure the optical density of
the bands of β1-AR and β2-AR. Data of β-AR protein levels for
WT and KO mice were expressed as percentage of the averaged
values of β-tubulin.
Open Field (OF)
Three days prior to locomotor activity assessments, mice were
habituated to the testing room for 30 min each day. During the
test, mice were released from the center of an OF test chamber
(20 × 20 cm2, ENV-515; Med Associates, Inc., St. Albans, VT,
USA) and were allowed to explore the arena freely for 30 min.
Total distance, distance and duration in the center area, entrance
times to the center area were analyzed using OFActivity Software
package v. 4.0 (MedAssociates, Inc.). Testing was conducted with
25 Lux illuminance in the chamber. In the test for locomotor
activity induced by acute cocaine administration, mice were
placed in the OF chamber for 30 min followed by another 60 min
after an injection of cocaine (20 mg/kg i.p.).
Light-Dark Box (L/D)
The light/dark box (46 × 27 × 30 cm) is composed of two
compartments: the dark compartment (one third of the box)
and the light compartment (two thirds of the box). Testing was
conducted with 25 Lux illuminance in the light box (Birkett
et al., 2011; Lehmann and Herkenham, 2011; Bluett et al., 2014;
Shonesy et al., 2014). Mice were placed in the center of the light
box and allowed full access to both compartments for 6 min. The
tasks were taped by a digital video camera and the time mice
spent in each compartment was analyzed with Clever System
software (CleverSys).
Elevated Plus Maze (EPM)
Anxiety-related behavior was also measured by EPM task as
previously described (Pravetoni and Wickman, 2008). Briefly,
the maze was elevated 50 cm above the ground and consisted
of two open arms, and two closed arms, as well as an exposed
center panel. The mice were placed in the center of the maze,
facing the closed arm. The sessions were taped by a digital video
camera for 6 min and the time spent in each arm was analyzed
with Clever System software (CleverSys). Time spent in the EPM
center was not included. Testing was conducted under standard
room lighting conditions.
Tail Suspension Test (TST)
The TST as one of the most widely used models for assessing the
antidepressant-like activity in mice was used in our experiment.
Mice were suspended 50 cm above the floor by the tip of the
tail (<2 cm) with adhesive tape from a horizontal bar and were
positioned such that the base of their tails was vertical to the
bottom of the bar. The tasks were taped by a digital video camera
for 5 min. Immobility was analyzed with the Tail Suspension
Software (CleverSys). Mice were considered immobile only when
they hung passively and completely motionless.
Forced Swimming Test (FST)
FST is another widely used model for assessing the
antidepressant-like activity in mice. Mice were gently
released into a transparent Plexiglas cylinder (diameter
10 cm, height 25 cm) filled with water (25 ± 0.5◦C, 20 cm
high) for a 5 min session (under <500 lux ambient light).
Immobility (i.e., cessation of limb movement except minor
involuntary movement of the hind limbs) was scored with the
ForcedSwimScan software (CleverSys). Each mouse was judged
to be immobile when it ceased struggling and remained floating
motionless in the water, making only those movements necessary
to keep its head above water as previous reported (Kaster et al.,
2007).
Cocaine Conditioned Place Preference
(Cocaine-CPP)
A two-chamber, unbiased CPP paradigm was applied in
accordance with the method previously employed (Liu et al.,
2015). The CPP apparatus consisted of two compartments
with distinct flooring and walls. Before each session mice
were habituated to the experimental room for at least 30 min.
On day 1, mice were allowed free access to both sides of
apparatus for 15 min, and the duration in the two different
chambers were recorded respectively. Mice with an initial
preference (>65% of total time) for either chamber were
excluded from the experiment. On day 2, mice were subjected
to the conditioning phase, they were confined to one of the
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conditioning compartments for 30 min after injection of saline
(4 ml/kg, AM) and confined to the other compartment after
injection of cocaine (10 mg/kg, PM). On day 3 the training
were conducted with switched order of the saline and cocaine
conditioning. On day 4 the conditioning was performed as
day 2. On day 5, mice were allowed free access to the entire
apparatus, and the duration in each side was recorded. During
the conditioning, clenbuterol or betaxolol were injected 30 min
before cocaine conditioning. The sessions were taped by a digital
video camera and the time spent in each chamber recorded by a
trained observer blind to the genotype and treatment. The CPP
preference was determined as score with time (s) spent in cocaine
paired side minus saline side.
Statistical Analysis
Experimental data were presented as the mean ± SEM and
analyzed by Sigmaplot 12.5. The behavioral results from OF,
L/D box, EPM, TST, FST and CPP were analyzed with one-way
ANOVA or two-way repeated measures (RM) ANOVA followed
by the Bonferroni’s post hoc test. The WB results were analyzed
with two-tailed Student’s t-test.
RESULTS
β2-AR Knock-Out Increases Level
of Anxiety
In general, β2-AR KO mice showed no genotype-dependent
differences in body weight, no obvious developmental
abnormalities, or deficits in touch, vision and hearing compared
with their WT littermates. To verify the deletion of β2-AR,
the hippocampus and mPFC were dissected from β2-AR KO
mice and WT mice for Western blot analysis (Figures 2A,B).
The results showed deficient expression of β2-AR and normal
FIGURE 2 | Anxiety level was elevated in β2-adrenoceptors (β2-AR) KO mice. (A) Representative images of β2-AR and β1-AR expression in the hippocampus
of the WT and β2-AR KO mice by WB analysis and the quantification of β1-AR and β2-AR expression in hippocampus membrane fractions. (B) Representative
images of β2-AR and β1-AR expression in the medial prefrontal cortex (mPFC) of the WT and β2-AR KO and the quantification of β1-AR and β2-AR expression in
mPFC membrane fractions. (C,D) The anxiety level of WT, HET and β2-AR KO mice. (C) Light/Dark box test WT: n = 27, HET: n = 17, β2-AR KO: n = 27. (D) Elevated
plus maze test. WT: n = 26, HET: n = 17, β2-AR KO: n = 27. Data are presented as mean ± SEM ∗p < 0.05 vs. WT, ∗∗p < 0.01 vs. WT, ∗∗∗p < 0.001 vs. WT.
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expression levels of β1-AR in the hippocampus and mPFC of the
β2-AR KOmice (Figure 2A, β2-AR: p< 0.001, β1-AR: p = 0.732;
Figure 2B, β2-AR: p = 0.024, β1-AR: p = 0.614, t-test).
In the L/D box and EPM tasks, both β2-AR KO and HET
mice spent significantly less amounts of time in the light
compartment and the open arms than WT mice (Figure 2C,
F(2,67) = 10.638, p < 0.001, one-way ANOVA; Figure 2D,
F(2,66) = 7.322, p = 0.001, one-way ANOVA). The results
from both tests consistently showed that the anxious state and
innate fear were increased by deletion of one or two copies of




Next, the performance of β2-AR KO mice was assessed in
TST and FST, two behavioral assays widely used to examine
behavioral despair in mice (Porsolt et al., 1977; Steru et al., 1985).
In TST, β2-AR KO mice displayed significantly less immobility
during the entire 5 min than WT and HET mice (Figure 3A,
F(2,43) = 6.315, p = 0.004, one-way ANOVA), however,
immobility time during each 5-min were indistinguishable of
the test (Figure 3B, Fgenotype × time(2,43) = 1.344, p = 0.255,
two-way RM ANOVA). In FST, immobility duration in total
FIGURE 3 | Depression-like behavior was suppressed in β2-AR KO
mice. The performance of WT, HET and β2-AR KO mice in Tail-suspension
(A,B) and Forced swimming (C,D) tests. Total immobility time during 5-min
period (A,C) in each 1-min block (B,D) are plotted. For tail-suspension test
(TST): WT: n = 12; HET: n = 18; KO: n = 16. For Forced swimming test (FST):
WT: n = 12; HET: n = 18; KO: n = 16). Data are presented as mean ± SEM
∗p < 0.05 vs. WT, ∗∗p < 0.01 vs. HET.
or each 5 min was comparable in β2-AR KO, HET and WT
mice (Figure 3C, F(2,43) = 1.137, p = 0.33, one-way ANOVA;
Figure 3D, Fgenotype × time(2,43) = 1.356, p = 0.219, two-way
RM ANOVA). These results suggest that behavioral despair is
suppressed by β2-AR ablation in TST.
β2-AR Knock-Out Increases Response
to Acute Cocaine
To assess the locomotor activity in β2-AR KO mice, the OF
task was performed. The data showed that the total distances
traveled by β2-AR KO mice, HET and WT littermates during
both the entire test period and each 5-min were indistinguishable
(Figure 4A, F(2,68) = 1.506, p = 0.229, one-way ANOVA;
Figure 4B, Fgenotype × time(2,68) = 1.506, p = 0.229, RM two-way
ANOVA). β2-AR KOmice did not show difference in time spent
in the center of the chamber and distance traveled, or number
of entries into the center of the OF chamber from HET and WT
mice (Figures 4C–E, F(2,68) = 2.857, p = 0.064; F(2,68) = 0.680,
p = 0.510; F(2,68) = 0.863, p = 0.462; one-way ANOVA). These
results indicate that β2-AR KO does not change locomotor
activity.
Acute cocaine (20 mg/kg, i.p.) administration significantly
increased total distance traveled in WT, HET and β2-AR
KO mice, but β2-AR KO mice displayed significantly higher
locomotor activity than WT and HET mice (Figure 4F,
Fgenotype × treatment(2,22) = 7.604, p = 0.003, two-way RMANOVA)
during a 60-min period following cocaine injection in the OF
test. Two-way RM ANOVA revealed a significant genotype by
time interaction and Bonferroni’s post hoc revealed that acute
cocaine treatment induced an enhanced locomotor activity in
β2-AR KO mice, the increase in locomotor activity primarily
took place during the first 35 min of the test (Figure 4G,
Fgenotype × time(2,22) = 4.132, p < 0.001). The results indicate




In the task of cocaine-CPP, all groups showed preference
for cocaine-paired side under the dose of 10 mg/kg
cocaine (Figure 5A). Two-way RM ANOVA revealed a
significant genotype by session interaction (Figure 5B,
Fgenotype × session(2,43) = 3.827, p = 0.03), and Bonferroni’s
post hoc revealed a significant higher preference for the
cocaine-paired side developed in β2-AR KO and HET mice
compared with WT mice, indicating β2-AR KO increased
rewarding properties of cocaine. To further verify the role
of β2-AR in cocaine rewarding effect, clenbuterol (5 mg/kg),
was administrated 30 min before each cocaine conditioning
session (Figure 5C). CPP scores were recorded 24 h after the
last conditioning session. Clenbuterol treatment significantly
reduced the preference for cocaine-paired side (Figure 5D,
Ftreatment × session(1,24) = 7.439, p = 0.012, two-way RM ANOVA).
With regard to the normal expression level of β1-AR in β2-AR
KOmice, the role of β1-AR in cocaine-CPP was tested. Betaxolol
(10 mg/kg) was given 30 min before cocaine conditioning daily
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FIGURE 4 | Locomotor response to acute cocaine administration increased in β2-AR KO mice. The performance of WT, HET and β2-AR KO mice in Open
field (OF) (A–E). (A) Total distance traveled in the whole arena for 30 min. (B) Distance traveled during each 5-min block in the whole arena. (C) Time spent and
(D) distance traveled in the center arena (one-quarter of the total area around the center of the arena). (E) Number of entrances into center arena (WT: n = 27, HET:
n = 17, KO: n = 27). Data are presented as the mean ± S.E.M. The locomotor activity induced by an injection of cocaine (20 mg/kg, i. p.) was tested after 30-min
adaptation in OF in WT, HET and β2-AR KO mice (F,G). (F) Total distance traveled in the whole arena for a 60-min duration after cocaine injection. (G) Distance
traveled during each 5-min block in the whole arena (WT: n = 9, HET: n = 6, KO: n = 9). Data are presented as the mean ± SEM. ∗p < 0.05 vs. WT and HET,
∗∗p < 0.01 vs. WT and HET, ∗∗∗p < 0.001 vs. WT and HET.
(Figure 5E). We found that betaxolol inhibited the preference
for cocaine-paired side in WT and β2-AR KO mice, however,
antagonism of β1-AR in β2-AR KO mice only reduced the
CPP score to the levels of cocaine-CPP developed in WT
mice rather than a completed disruption, further suggesting
that β2-AR deletion enhanced rewarding effect of cocaine
(Figure 5F left, Ftreatment × session(1,40) = 4.176, p = 0.048, two-way
RM ANOVA; Figure 5F right, Ftreatment × session(1,29) = 4.667,
p = 0.039, two-way RM ANOVA). The above results indicate
that β2-AR might suppress rewarding effects induced
by cocaine, producing effects opposite to the function
of β1-AR.
DISCUSSION
To investigate the role of β2-AR in stressful or emotional
behaviors, a battery of behavioral tests was performed on β2-AR
KO mice. In this study, the β2-AR KO mice showed increased
preference for the dark compartment and closed arm in L/D and
EPM tests. β2-AR KO mice also showed decreased immobility
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FIGURE 5 | Preference for cocaine paired side was enhanced in β2-AR KO mice. The cocaine-CPP was conducted in WT, HET and β2-AR KO mice. After
three daily conditioning, mice were tested for the preference for cocaine paired side. (A,B) Cocaine-CPP procedure (A) and the memory retention test (B). WT:
n = 18, HET: n = 8, KO: n = 20. ∗p < 0.05 vs. WT. (C,D) Cocaine-CPP procedure (C) and the memory retention test (D) for C57 mice. Clenbuterol (Clen, 5 mg/kg,
i.p.) or saline was administrated 30 min before cocaine conditioning. n = 14–20 per group. ∗p < 0.05 vs. saline group. (E,F) Cocaine-CPP procedure (E) and the
memory retention test (F) for WT (left) and β2-AR KO (right) mice. Betaxolol (Bet, 10 mg/kg, i.p.) or saline was injected 30 min before cocaine conditioning. WT/Sal:
n = 24, WT/Bet: n = 18, KO/Sal: n = 17, KO/Bet: n = 14). Data are presented as the mean ± SEM. ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. saline group.
in TST. Interestingly, β2-AR deletion did not change basal
locomotor activity, but significantly increased locomotor activity
induced by acute cocaine administration and greatly enhanced
preference for cocaine, which was significantly attenuated by
betaxolol, the selective β1-AR antagonist. Consistently, the
β2-AR agonist disrupted preference for cocaine. Our results
suggest that β2-AR play pivotal roles in regulating anxiety,
depression-like behaviors and reward induced by cocaine.
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β2-AR are widely distributed in the brain, including
frontal and piriform cortices, the medial septal nuclei,
the olfactory tubercle, the hippocampus and the midbrain
(Asanuma et al., 1991). In this study, WB analysis of β2-AR
KO mice showed reduction of β2-AR expression in the
hippocampus and mPFC, which are involved in cognitive
function, emotional regulation, self-regulation, goal-directed
behaviors, neuroendocrine and autonomic function (McEwen
and Morrison, 2013). It is reported that β2-AR activation in
mPFC promotes memory consolidation through cAMP-PKA
signaling (Zhou et al., 2013) and the expression of β2-AR
in hippocampal CA3 is required for long-term memory
consolidation (Zheng et al., 2015). However, the roles of β2-AR
expression in the regulation of emotional behaviors are largely
unknown.
In this study, β2-AR KO and HET mice showed decreased
duration in the light compartment and open arms in L/D box
and EPM tasks, indicating an increased anxiety or innate fear by
β2-AR deletion. Considering that β1-AR antagonism attenuates
the anxiety-like behavior during early withdrawal from chronic
cocaine administration in rats, and β1-AR antagonist infusion
in the basolateral amygdala facilitated anxiolytic effect (Rudoy
and Van Bockstaele, 2007; Fu et al., 2008). Our data suggest
that the balance between β1-AR and β2-AR might be critical for
the regulation sensitivity of anxiety-like behavior. However, it is
also possible that β2-AR KO might influence the cardiovascular
system, which also correlates with the anxiety level (Nabi et al.,
2010; Roest et al., 2010; Balasubramaniyan et al., 2016; Williams
et al., 2016). In this study, no difference in the exploration
of central area in OF task was detected, not consistent with
the results of reduced anxiety in L/D box and EPM test. This
discrepancy may be ascribed to the size of box applied for OF
task. The box used for OF was relatively small (20× 20 cm2) and
not sensitive for examining the innate anxiety level in mice.
Considering the high rate of comorbid anxiety and depression
disorders (Aderka et al., 2015), depression level of mice was
subsequently tested by TST and FST, the classic animal models
for detecting depression-like behavior (Cryan and Mombereau,
2004; Cryan et al., 2005; Petit-Demouliere et al., 2005). In this
study, β2-ARKOmice exhibited an antidepressant-like behavior,
characterized by decreased immobility time in the TST, but not
in FST task.
β-ARs also play a critical role in drug addiction. β-AR
blockade by propranolol produces a dose-related increase in
cocaine-induced motor activity and a decrease in cocaine
self-administration (Harris et al., 1996); impairs the retrieval,
expression and reinstatement of cocaine-CPP in rats (Otis and
Mueller, 2011; Otis et al., 2014); disrupts alcohol withdrawal
in human and naloxone-precipitated morphine withdrawal
in rats (Carlsson and Fasth, 1976; Bouton, 1993; Watanabe
et al., 2003). However, the effects of β2-AR in drug addiction
have not been identified yet. In our study, β2-AR KO mice
showed increased response and higher rewarding properties
to cocaine in the locomotion and CPP tests. Additionally,
β2-AR KO mice showed high motivational effects of cocaine
in coincident with the higher anxiety-like behavior observed
in elevated plus maze and light-dark box model, consistent
with the previous studies, which demonstrated that anxiety-like
behavior predicted cocaine-CPP (i.e., the more anxious mice
showed more preference for the cocaine-paired compartment)
and anxiety increased vulnerability for cocaine (Ladrón de
Guevara-Miranda et al., 2016). Hence, β2-AR may be a
potential target for the treatment of anxiety and cocaine
addiction.
In another aspect, the individual roles of β1/β2-AR in
cocaine addiction are not clear. Vranjkovic et al. (2012)
reported that both WT and β1/β2-AR double KO mice
developed CPP, and no difference in cocaine-CPP was detected
between both genotypes. Intriguingly, we also found that β1-AR
antagonist betaxolol injected before cocaine conditioning did
not completely attenuate the preference for cocaine in β2-AR
KO mice, but only reduced the CPP scores to a similar
level of WT mice after cocaine-CPP training. Accordingly, we
speculated that β1-AR and β2-AR might play opposite roles in
the regulation of cocaine CPP. Previous studies also suggested
that selective blockade of β1-AR not β2-AR induces a persistent
retrieval deficit of cocaine-associated memory and contextual
fear conditioning (Murchison et al., 2004; Fitzgerald et al., 2016).
Furthermore, both β1-AR and β2-AR can influence memory
reconsolidation (Bernardi et al., 2009; Liu et al., 2015). However,
the role of different types of β-AR in drug addiction and
psychiatric disorders needs further research by β2-AR antagonist
or β1-AR agonist. For example, antagonism of β2-AR in the β1-
AR knockout mice or activation of β1-AR in the WT mice will
be performed next to make it more clearly how these two β-ARs
affect cocaine-CPP.Moreover, conditional knockout of β1-AR or
β2-AR will be used to find out the role of β-ARs in different brain
regions in anxiety, depression or rewarding properties of cocaine.
Taken together, our study indicates that β2-AR play
critical roles in regulating anxiety-like behaviors and rewarding
properties of cocaine. Our findings provide new insights into
the physiological and pathological roles of β2-AR and a potential
target for treatment of anxiety disorder and cocaine abuse.
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